Table 1.
Initial assessment | Follow up I | Follow up II | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total (n = 239) | Shoulder pain (n = 133) | No shoulder pain (n = 106) | P- value | Total (n = 239) | Shoulder pain (n = 142) | No shoulder pain (n = 97) | P- value | Total (n = 236) | Shoulder pain (n = 136) | No shoulder pain (n = 100) | P- value | |
Age, (y) (x ± SD) | 70 ± 9 (50, 94) | 71 ± 9 (52,94) | 70 ± 9 (50,91) | 0.564 | 70 ± 9 (50,94) | 71 ± 9 (52,94) | 70 ± 9 (50,91) | 0.418 | 70 ± 9 (50,94) | 71 ± 9 (52,94) | 70 ± 9 (50,91) | 0.495 |
Male, n (%) | 148 (62%) | 75 (56%) | 73 (69%) | 148 (62%) | 80 (56%) | 68 (70%) | 146 (62%) | 75 (55%) | 71 (71%) | |||
Female, n (%) | 91 (38%) | 58 (44%) | 33 (31%) | 0.048* | 91 (38%) | 62 (44%) | 29 (30%) | 0.031* | 90 (38%) | 61 (45%) | 29 (29%) | 0.013* |
Past medical history | ||||||||||||
Hypertention, n (%) | 201 (84%) | 111 (84%) | 90 (85%) | 0.761 | 201 (84%) | 118 (83%) | 83 (86%) | 0.608 | 199 (84%) | 114 (84%) | 85 (85%) | 0.806 |
Atrial fibrillation, n (%) | 31 (13%) | 22 (17%) | 9 (9%) | 0.066 | 31 (13%) | 23 (16%) | 8 (8%) | 0.072 | 30 (13%) | 21 (15%) | 9 (9%) | 0.142 |
Main type stroke | ||||||||||||
Infarction, n (%) | 197 (82%) | 106 (80%) | 91 (86%) | 0.241 | 197 (82%) | 115 (81%) | 82 (85%) | 0.409 | 195 (83%) | 110 (81%) | 85 (85%) | 0.388 |
Cerebral hemorrhage, n (%) | 39 (16%) | 26 (20%) | 13 (12%) | 39 (16%) | 26 (18%) | 13 (13%) | 38 (16%) | 25 (18%) | 13 (13%) | |||
Subarachnoid hemorrhage, n (%) | 3 (1%) | 1 (1%) | 2 (2%) | 3 (1%) | 1 (1%) | 2 (2%) | 3 (1%) | 1 (1%) | 2 (2%) | |||
Hemiplegic side | ||||||||||||
Left, n (%) | 115 (48%) | 66 (50%) | 49 (46%) | 0.601 | 115 (48%) | 68 (48%) | 47 (49%) | 0.931 | 113 (48%) | 64 (47%) | 49 (49%) | 0.768 |
Right, n (%) | 121 (51%) | 65 (49%) | 56 (53%) | 0.543 | 121 (51%) | 72 (51%) | 49 (51%) | 0.977 | 120 (51%) | 70 (52%) | 50 (50%) | 0.823 |
Both, n (%) | 3 (1%) | 2 (2%) | 1 (1%) | 1.000 | 3 (1%) | 2 (1%) | 1 (1%) | 1.000 | 3 (1%) | 2 (2%) | 1 (1%) | 1.000 |
Stroke location | ||||||||||||
Massive, n (%) | 27 (11%) | 25 (19%) | 2 (2%) | <0.001** | 27 (11%) | 26 (18%) | 1 (1%) | <0.001** | 27 (11%) | 26 (19%) | 1 (1%) | <0.001** |
Cortical, n (%) | 38 (16%) | 21 (16%) | 17 (16%) | 0.958 | 38 (16%) | 23 (16%) | 15 (16%) | 0.879 | 38 (16%) | 22 (16%) | 16 (16%) | 0.971 |
Brain stem, n (%) | 34 (14%) | 18 (14%) | 16 (15%) | 0.732 | 34 (14%) | 17 (12%) | 17 (18%) | 0.227 | 33 (14%) | 16 (12%) | 17 (17%) | 0.252 |
Pontine, n (%) | 20 (8%) | 13 (10%) | 7 (7%) | 0.379 | 20 (8%) | 13 (9%) | 7 (7%) | 0.595 | 19 (8%) | 12 (9%) | 7 (7%) | 0.611 |
Basal gangregion, n (%) | 35 (15%) | 20 (15%) | 15 (14%) | 0.847 | 35 (15%) | 21 (15%) | 14 (14%) | 0.939 | 34 (14%) | 20 (15%) | 14 (14%) | 0.879 |
Thalamic, n (%) | 9 (4%) | 8 (6%) | 1 (1%) | 0.088 | 9 (4%) | 8 (6%) | 1 (1%) | 0.136 | 9 (4%) | 8 (6%) | 1 (1%) | 0.112 |
Undefined, n (%) | 8 (3%) | 4 (3%) | 4 (4%) |
% indicates proportion of the total group in each column.
**P < 0.01, significant differences between the groups with and without shoulder pain; *P < 0.05, significant differences between the groups with and without shoulder pain.